Abstract:MTOR (mechanistic target of rapamycin kinase) complex 1 (MTORC1) orchestrates diverse environmental signals to facilitate cell growth and is frequently activated in cancer. Translocation of MTORC1 from the cytosol to the lysosomal surface by the RRAG GTPases is the key step in MTORC1 activation. Here, we demonstrated that transcription factors MEF2A and MEF2D synergistically regulated MTORC1 activation via modulating its cyto-lysosome shutting. Mechanically, MEF2A and MEF2D controlled the transcription of FNIP1 and FNIP2, the components of the FLCN-FNIP1 or FNIP2 complex that acts as a RRAGC-RRAGD GTPase-activating element to promote the recruitment of MTORC1 to lysosome and its activation. Furthermore, we determined that the pro-oncogenic protein kinase SRC/c-Src directly phosphorylated MEF2D at three conserved tyrosine residues. The tyrosine phosphorylation enhanced MEF2D transcriptional activity and was indispensable for MTORC1 activation. Finally, both the protein and tyrosine phosphorylation levels of MEF2D are elevated in human pancreatic cancers, positively correlating with MTORC1 activity. Depletion of both MEF2A and MEF2D or expressing the unphosphorylatable MEF2D mutant suppressed tumor cell growth. Thus, our study revealed a transcriptional regulatory mechanism of MTORC1 that promoted cell anabolism and proliferation and uncovered its critical role in pancreatic cancer progression.Abbreviation: ACTB: actin beta; ChIP: chromatin immunoprecipitation; EGF: epidermal growth factor; EIF4EBP1: eukaryotic translation initiation factor 4E binding protein 1; FLCN: folliculin; FNIP1: folliculin interacting protein 1; FNIP2: folliculin interacting protein 2; GAP: GTPase activator protein; GEF: guanine nucleotide exchange factors; GTPase: guanosine triphosphatase; LAMP2: lysosomal associated membrane protein 2; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MEF2: myocyte enhancer factor 2; MEF2A: myocyte enhancer factor 2A; MEF2D: myocyte enhancer factor 2D; MEF2D-3YF: Y131F, Y333F, Y337F mutant; MTOR: mechanistic target of rapamycin kinase; MTORC1: MTOR complex 1; NR4A1: nuclear receptor subfamily 4 group A member 1; RPTOR: regulatory associated protein of MTOR complex 1; RHEB: Ras homolog, mTORC1 binding; RPS6KB1: ribosomal protein S6 kinase B1; RRAG: Ras related GTP binding; RT-qPCR: real time-quantitative PCR; SRC: SRC proto-oncogene, non-receptor tyrosine kinase; TMEM192: transmembrane protein 192; WT: wild-type.

Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia.

Article Through Inhibiting STAT3 Phosphorylation and Nuclear Translocation

Role of FLCN Phosphorylation in Insulin‐Mediated Mtorc1 Activation and Tumorigenesis

Flcn-deficient Renal Cells Are Tumorigenic and Sensitive to Mtor Suppression

FLCN Regulates HIF2α Nuclear Import and Proliferation of Clear Cell Renal Cell Carcinoma

Correction: Deficiency of FLCN in Mouse Kidney Led to Development of Polycystic Kidneys and Renal Neoplasia

Folliculin, a Tumor Suppressor Associated with Birt-Hogg-Dubé (BHD) Syndrome, is a Novel Modifier of TDP-43 Cytoplasmic Translocation and Aggregation.

Folliculin Regulates Cell-Cell Adhesion, AMPK, and Mtorc1 in a Cell-Type-specific Manner in Lung-Derived Cells.

FHL1 Inhibits the Growth of Tongue Squamous Cell Carcinoma Cells Via G1/S Cell Cycle Arrest.

The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect

FLCN regulates transferrin receptor 1 transport and iron homeostasis

Folliculin variants linked to Birt-Hogg-Dubé syndrome are targeted for proteasomal degradation

A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dubé syndrome

56 Zinc Finger Protein 545 is a Functional Tumor Suppressor Through Inhibiting Ribosomal RNA Transcription in Gastric Cancer

Mtorc2 Mediate FLCN-induced HIF2α Nuclear Import and Proliferation of Clear Cell Renal Cell Carcinoma

Direct Regulation of FNIP1 and FNIP2 by MEF2 Sustains MTORC1 Activation and Tumor Progression in Pancreatic Cancer.

Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway.

FLCN Maintains the Leucine Level in Lysosome to Stimulate Mtorc1

FHL1 Inhibits the Progression of Colorectal Cancer by Regulating the Wnt/β-Catenin Signaling Pathway

The primary cilium protein folliculin is part of the autophagy signaling pathway to regulate epithelial cell size in response to fluid flow

LZTFL1 inhibits kidney tumor cell growth by destabilizing AKT through ZNRF1-mediated ubiquitin proteosome pathway